RNA-Based Cancer Therapeutics : Techniques, Applications and Challenges in Prognosis
Idioma: inglés
Editorial: Springer, 2025
- Tapa dura
- Nuevo

Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Vendedor de IberLibro desde 14 de agosto de 2006
Condición: Nuevo
EUR 265,14
Cantidad disponible: 1 disponible
Añadir al carritoDescripción del artículo del vendedor
Druck auf Anfrage Neuware - Printed after ordering - By consistently dedicating efforts to multi-omic and other high-throughput technologies, it is expected that RNA therapies will have a vital role in future personalized medicine approaches for cancer therapy. Within this framework, analyzing the genetic sequence of a patient's tumor would allow for the detection of crucial driver mutations or changes that cause resistance to drugs. These mutations may then be targeted with RNA therapies that are particularly designed to treat those particular variations. Recent clinical trials have shown that RNA-based therapies hold great potential for treating several illnesses. However, further investigations are required to improve the delivery materials and understand the RNA alterations linked to these groundbreaking drugs, in order to facilitate their integration into clinical practice. Ideally, these therapeutic substances would be specifically administered to the tumor cells of interest using a targeted delivery agent. In this hypothetical situation, the choice of medications for cancer patients would differ depending on the precise abnormalities detected in each person, potentially including inhibitors that target circuits known to cause resistance to treatments. However, doing a more thorough assessment of the challenges and potential benefits discussed in each chapter would enhance the capacity to critically analyze this rapidly evolving field of therapies. This book largely examines the latest developments and clinical studies related to RNA-based medications, while also examining the challenges and future possibilities linked with them. This method shows potential for greatly improving the prognosis of cancer patients.…
N° de ref. del artículo 9789819634552
- Título
- RNA-Based Cancer Therapeutics : Techniques, Applications and Challenges in Prognosis
- Autor
- Gulshan Wadhwa
- Editorial
- Springer
- Año de publicación
- 2025
- Estado
- Neu
- Encuadernación
- Buch
- Idioma
- inglés
- ISBN 10
- 9819634555
- ISBN 13
- 9789819634552
- Peso del artículo
- 633 gramos
- Dimensiones
- 241x160x23 mm
By consistently dedicating efforts to multi-omic and other high-throughput technologies, it is expected that RNA therapies will have a vital role in future personalized medicine approaches for cancer therapy. Within this framework, analyzing the genetic sequence of a patient's tumor would allow for the detection of crucial driver mutations or changes that cause resistance to drugs. These mutations may then be targeted with RNA therapies that are particularly designed to treat those particular variations. Recent clinical trials have shown that RNA-based therapies hold great potential for treating several illnesses. However, further investigations are required to improve the delivery materials and understand the RNA alterations linked to these groundbreaking drugs, in order to facilitate their integration into clinical practice. Ideally, these therapeutic substances would be specifically administered to the tumor cells of interest using a targeted delivery agent. In this hypothetical situation, the choice of medications for cancer patients would differ depending on the precise abnormalities detected in each person, potentially including inhibitors that target circuits known to cause resistance to treatments. However, doing a more thorough assessment of the challenges and potential benefits discussed in each chapter would enhance the capacity to critically analyze this rapidly evolving field of therapies. This book largely examines the latest developments and clinical studies related to RNA-based medications, while also examining the challenges and future possibilities linked with them. This method shows potential for greatly improving the prognosis of cancer patients.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Dr. Narendra Kumar Sharma
Dr. Narendra Kumar Sharma is working as Assistant Professor at the Department of Biosciences and Biotechnology of the Banasthali Vidyapith, India. He has earlier served as Post-doctoral Fellow at Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), China and Post-doctoral Fellow at Federal University of Sao Paulo (UNIFESP), Brazil. His research interest is in Genomics and Proteomics with specialization in hypoxia physiology, oxidative stress, post-translational modification, protein biochemistry, signaling pathway, infectious disease and genome editing. He has been conferred with several national and international awards including Young Scientist and Innovation Award. He has served as a referee for a number of international journals. He has also published more than 30 research articles in peer-reviewed international journals and authored or co-authored books and book chapters.
Dr. Tikam Chand Dakal
Dr. Tikam Chand Dakal is presently working as an Assistant Professor at Mohanlal Sukhadia University, Udaipur (Rajasthan). Dr. Dakal is also the State Vice-President of the Microbiologists Society India. Dr. Dakal has been listed among the Top-2% Scientist of the World by Stanford University, USA. Dr. Dakal did his Ph.D. from Italy and has postdoctoral experience from Canada and France. Dr. Dakal has worked as a Senior Scientist at Beckman Research Institute of the City of Hope, California, USA. Dr. Dakal has been conferred with the prestigious FEMS-Young Science Award by FEMS - Germany. Dr. Dakal is also recipient of Best Teacher, Best Researcher and Best Paper awards by prestigious scientific societies. Dr. Dakal is also a member of different academic societies in India and abroad. Dr. Dakal has published more than 80 papers in peer-reviewed journals of international repute and has citations more than 2800 and h-index 20. Dr. Dakal is also serving as Associate Editor, Guest Editor and Review Editor of a number of journals. Dr. Dakal has delivered more than 40 invited lectures and has also been invited as resource person for UGC-HRDC programs and other Government of India sponsored conferences, workshops, seminars etc. Dr. Dakal has also organized a number of International, National conferences, seminars and workshops on different topics. Dr. Dakal is presently working in the field of genome and computational biology and has successfully completed 2 extramural research projects from DST and UGC.
Prof. Pawan Kumar Maurya
Prof. Pawan Kumar Maurya is Dean, School of Life Long Learning & Head of Department of Biochemistry, Central University of Haryana, India. He has done a PhD from the University of Allahabad (A Central University), India & post-doctoral training from Universidade Federal de Sao Paulo-UNIFESP, Brazil; Taipei Medical University (TMU) and National Taiwan University (NTU), Taiwan. He has more than 14 years of teaching and research experience. He is working on biochemical diagnostics, nanomedicine, and clinical biochemistry. He has published over 92 research articles in reputed publication. He has also edited of 11 books in reputed publication. He is recipient of prestigious fellowships: Science without Borders (Government of Brazil) and National Science Council, Taiwan.
Dr Gulshan Wadhwa
Dr. Gulshan Wadhwa is Presently working as Adviser & Scientist ‘G’ at Department of Biotechnology, Ministry of Science & Technology, New Delhi. The present job profile includes Outreach Division with DBT website, Conference, Travel, Exhibition and Popular Lectures CTEP program dealing with more than 2500 applications every year and supporting more than 600-800 programs in these areas. These programs were initiated and handled by him in 2009. The India International Science Festival, BIO-India, competitive Grant System, Direct benefit transfer and UMANG protocol are the other areas being looked after by him. He is also involved in establishment and coordinate activities of 170 Bioinformatics Centers established at Bioinformatics Division, DBT, including 6 Centers of Excellence in Bioinformatics, 12 DICs and 48 Sub-DICs and the Apex Bioinformatics Centre at DBT, 103 BIF facilities, 6 Graphics Facilities, 6 M.Sc./M.Tech. programmes/Advanced Diploma courses in Bioinformatics at various locations all over the country and a Super Computing Facility at IIT Delhi. Financial support and physical monitoring of the Programme, centers and more than 200 R&D projects in Bioinformatics. Dr Wadhwa is also worked for International Cooperation with South American Countries. MoU has been signed with 3 countries viz. Brazil, Cuba and Costa Rica and collaborative projects are being supported, Animal Biotechnology and Aquaculture, National and International Exhibitions, State Partnership Programme with Madhya Pradesh, Direct Benefit Transfer scheme of the Department, Umang Portal.
“Acerca de” puede pertenecer a otra edición de este título.
AHA-BUCH GmbH
Einbeck, Alemania
Vendedor de IberLibro desde 14 de agosto de 2006
Tarifas de envío de Alemania a Estados Unidos de America
| Artículo | De 7 a 10 días hábiles | De 5 a 7 días hábiles |
|---|---|---|
| Primer artículo | EUR 35,00 | EUR 45,00 |
Métodos de pago
- Cheque
- Giro bancario
- PayPal
Descripción de la tienda
Das Unternehmen AHA-BUCH GmbH: Seit der Gründung von AHA-BUCH im Juli 2005 ist unser Hauptziel, zufriedenen Kunden so schnell und so preisgünstig wie möglich ihren Bücherwunsch zu erfüllen. Unsere Firma beschäftigt 16 Mitarbeiter, die nur ein Ziel kennen: den Kunden und seine Wünsche! Auf über 3700 m2 Fläche haben wir über 100.000 Bücher, Modernes Antiquariat und Spiele auf Lager.
Especialidad
Kinderbücher & Kinderhör Casetten, German Books, Software, Natur & Tiere, Ratgeber, Sachbücher, Englische Bücher, Medizin & Gesundheit, Universität & StudiumInformación empresarial del vendedor
AHA-BUCH GmbH
Garlebsen 48
Einbeck, Alemania 37574
Condiciones de venta
IImprint
Información del vendedor
AHA-BUCH GmbH
representado por el director gerente Christel Glass
Garlebsen 48
37574 Einbeck
Alemania
Teléfono: 055639996039
Fax: 055639995974
E-Mail: abebooks@aha-buch.de
USt-IdNr.: DE261904229
Inscrita en el Registro Mercantil Amtsgerichtes Göttingen
Handelsregisternummer HRB 200691
Resolución alternativa de conflictos:
La Comisión Europea proporciona una plataforma para la resolución extrajudicial de litigios en línea (plataforma ODR), a la que se puede acceder en https://ec.europa.eu/odr.
Somos miembros de la iniciativa "FairCommerce" desde el 25.05.2018.
Para obtener más información, consulte www.fair-commerce.de.
Derecho al desistimiento
Si es un consumidor, puede rescindir el contrato de acuerdo con lo siguiente. Por consumidor se entiende cualquier persona física que actúe con fines ajenos a su actividad comercial, empresarial, oficio o profesión.
Información sobre el derecho de desistimiento
Derecho legal de desistimiento
Tiene derecho a rescindir este contrato en un plazo de 14 días sin dar ningún motivo.
El periodo de desistimiento vencerá a los 14 días desde que usted, o un tercero que no sea el transportista e indicado por usted, adquiera la posesión física del último bien o del último lote o pieza.
Para ejercer el derecho de desistimiento, complete de forma electrónica y envíe una declaración clara en nuestro sitio web, desde "Mis compras" en "Mi cuenta". Le enviaremos sin demora un acuse de recibo de dicho desistimiento a través de un soporte duradero (por ejemplo, por correo electrónico).
Para cumplir con el plazo de desistimiento, basta con que envíe su comunicación relativa al ejercicio del derecho de desistimiento antes de que venza el periodo de desistimiento.
Efectos del desistimiento
Si rescinde este contrato, le reembolsaremos todos los pagos que hayamos recibido de usted, incluidos los gastos de envío (excepto los gastos adicionales que surjan si elige un tipo de envío que no sea el tipo de envío estándar más económico que ofrecemos).
Podemos hacer una deducción del reembolso por la pérdida de valor de cualquier bien suministrado, si la pérdida es el resultado de una manipulación innecesaria por su parte.
Efectuaremos el reembolso sin demoras indebidas y, a más tardar, 14 días después de que se nos informe de su decisión de rescindir este contrato.
Efectuaremos el reembolso utilizando el mismo medio de pago que utilizó para la transacción inicial, a menos que haya acordado expresamente lo contrario; en cualquier caso, no incurrirá en ningún cargo como resultado de dicho reembolso.
Podremos retener el reembolso hasta que hayamos recibido los bienes o hasta que nos haya presentado una prueba de que los ha devuelto, lo que ocurra primero.
Deberá devolver los bienes o entregarlos a AHA-BUCH GmbH, Einbeck, Germany, sin demoras indebidas y, en cualquier caso, en un plazo máximo de 14 días a partir del día en que nos comunique su desistimiento del presente contrato. El plazo se cumple si devuelve la mercancía antes de que venza el periodo de 14 días. Tendrá que asumir los gastos directos de devolución de los bienes. Usted solo es responsable de la disminución del valor de los bienes como resultado de una manipulación distinta a la necesaria para establecer la naturaleza, las características y el funcionamiento de los bienes.
Excepciones al derecho de desistimiento
El derecho de desistimiento no se aplica a lo siguiente:
- La entrega de periódicos, diarios o revistas, con la excepción de los contratos de suscripción; y
- El suministro de contenido digital que no se proporcione en un soporte tangible (por ejemplo, en un CD o DVD) si, al hacer el pedido, aceptó que podíamos empezar a entregarlo y que no podría desistir una vez iniciada la entrega.
Condiciones de envío
Enviamos su pedido después de recibirlos
para artículos disponibles las últimas 24 horas,
para artículos con suministro nocturno a más tardar 48 horas.
En caso de que necesitemos pedir un artículo a nuestro proveedor, nuestro tiempo de envío depende de la fecha de recepción de los artículos, pero los artículos se enviarán el mismo día.
Nuestro objetivo es enviar los artículos pedidos de la manera más rápida, pero también más eficiente y segura a nuestros clientes.